Zydus Cadila may soon seek emergency use authorization (EUA) for its DNA-plasmid technology-based COVID-19 vaccine from India’s drug regulator. If approved, this would be the first DNA-plasmid vaccine in the world. This could also be India’s first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator.